Yüklüyor......
Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers
Immune checkpoint inhibition has transformed cancer treatment. For gastroesophageal cancer, this class of drugs have demonstrated durable responses and survival benefit in a subgroup of patients, resulting in regulatory approval. However, several recent randomized phase III studies in gastroesophage...
Kaydedildi:
| Yayımlandı: | Front Oncol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243739/ https://ncbi.nlm.nih.gov/pubmed/32500029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00763 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|